SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

OMXH 25 NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

Orion: Click to view the issuer\'s details

Last update : 03/04/2012  >View issuer details

2019.04.29 | 14:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce U.S. FDA accepts New Drug Application for review and grants Priority Review for darolutamide - HTML (w)

2019.04.25 | 11:30 | Share History / Voting Rights and Number of Shares

English version HTML (w) Mail

puce Decision by the Board of Directors to acquire own shares - HTML (w)

2019.04.25 | 11:00 | Periodic information / 1st Quarter Information

English version HTML (w) Mail

puce Orion Group Interim Report January-March 2019 - HTML (w)

2019.04.16 | 08:00 | Share History / Voting Rights and Number of Shares

English version HTML (w) Mail

puce 297,000 Orion Corporation A shares converted into B shares - HTML (w)

2019.04.11 | 09:30 | Permanent Information Releases / Notification of availability

English version HTML (w) Mail

puce Publishing of Orion Corporation's Interim Report for January-March 2019 on 25 April 2019 - HTML (w)

2019.03.27 | 14:16 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Invitation to Orion's Capital Markets Day in Helsinki on Wednesday 22 May 2019 - HTML (w)

2019.03.26 | 16:30 | Annual General Meeting / AGM

English version HTML (w) Mail

puce Orion Corporation: Organising meeting of the Board of Directors - HTML (w)

2019.03.26 | 15:45 | Annual General Meeting / AGM

English version HTML (w) Mail

puce Orion Corporation: Decisions by the AGM on 26 March 2019 - HTML (w)

2019.03.08 | 07:30 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Darolutamide submitted for European marketing authorization - HTML (w)

2019.03.05 | 07:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Darolutamide submitted for marketing authorization in Japan - HTML (w)

2019.03.04 | 11:00 | Permanent Information Releases / Notification of availability

English version HTML (w) Mail

puce Orion Group Financial Statement documents 2018 and Corporate Governance Statement published - HTML (w)

2019.03.01 | 18:10 | Share History / Voting Rights and Number of Shares

English version HTML (w) Mail

puce Orion Corporation: Transfer of 47,279 own B shares on 1 March 2019 - HTML (w)

2019.02.27 | 06:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce The rolling submission to FDA for darolutamide in the U.S. completed - HTML (w)

2019.02.11 | 15:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Orion and Propeller Health partner to bring new digital medicines to people with asthma and COPD - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 188